Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors von Weir, Matthew R, Bakris, George L, Bushinsky, David A, Mayo, Martha R, Garza, Dahlia, Stasiv, Yuri, Wittes, Janet, Christ-Schmidt, Heidi, Berman, Lance, Pitt, Bertram

Volltext

[PP.25.23] FACTORS INFLUENCING RESISTANCE TO DRUG THERAPY IN PATIENTS WITH ESSENTIAL HYPERTENSION von Bezrodna, L., Svyshchenko, Y., Bezrodnyi, V., Matova, O., Kupchinska, O., Sheremet, M.

Volltext

INSULIN RESISTANCE AND RENAL FUNCTION IN HYPERTENSIVE NEPHROPATHY PATIENTS: PP.8.216 von Bezrodnyy, V., Svyshchenko, Y., Bezrodna, Mishchenko

Volltext

EFFECTS OF ACE INHIBITOR PERINDOPRIL AND CALCIUM ANTAGONIST LERCANIDIPINE ON LIPIDS PROFILE IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE: PP.23.451 von Bezrodna, L, Svyshchenko, Y, Bezrodnyy, V, Mishchenko, L

Volltext

RELATIONSHIP BETWEEN LOW-GRADE INFLAMMATION, URIC ACID, LIPIDS AND RENAL FUNCTION IN HYPERTENSIVE PATIENTS: PP.30.207 von Bezrodnyy, V, Svyshchenko, Y, Mishchenko, L, Bezrodna, L

Volltext